RxSight (RXST) Change in Receivables (2020 - 2026)
RxSight's (RXST) quarterly Change in Receivables came in at -$936000.0 in Q1 2026, down 200.86% YoY from $928000.0 in Q1 2025, and down 18.78% on a QoQ basis from -$788000.0 in Q4 2025.
RxSight (RXST) Change in Receivables (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Change in Receivables data on file, last reported at -$936000.0 in Q1 2026.
- Quarterly Change in Receivables fell 200.86% year-over-year to -$936000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.5 million (down 190.03% YoY) and the FY2025 annual result came in at -$6.7 million, down 167.89% from the prior year.
- Change in Receivables slipped to -$936000.0 in Q1 2026, from -$788000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $5.0 million in Q4 2023 to a low of -$3.9 million in Q3 2025.
- A 5-year average of $1.0 million and a median of $1.3 million in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables jumped 566.45% — and 2025, when it sank 1120.94%.
- Tracing RXST's Change in Receivables over 5 years: stood at $1.9 million in 2022, then jumped by 160.31% to $5.0 million in 2023, then fell by 7.05% to $4.7 million in 2024, then plunged by 116.83% to -$788000.0 in 2025, then decreased by 18.78% to -$936000.0 in 2026.
- The last three Change in Receivables figures came in at -$936000.0 (Q1 2026), -$788000.0 (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | -3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.73 Mn |
| Jun 30, 2026 | -3.73 Mn |
| Mar 31, 2026 | -936,000.00 |
| Mar 31, 2026 | -936,000.00 |
| Dec 31, 2025 | -788,000.00 |
| Dec 31, 2025 | -788,000.00 |
| Sep 30, 2025 | -3.91 Mn |
| Sep 30, 2025 | -3.91 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Mar 31, 2025 | 928,000.00 |
| Mar 31, 2025 | 928,000.00 |
| Dec 31, 2024 | 4.68 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | -320,000.00 |
| Sep 30, 2024 | -320,000.00 |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.27 Mn |